Loading...
Loading...
- MaxCyte Inc MXCT appointed Ron Holtz, current Senior Vice President, and Chief Accounting Officer, as the Interim Chief Financial Officer.
- The change comes as Amanda Murphy has resigned from her position as Chief Financial Officer, effective as of April 15, 2022, to pursue other interests.
- MaxCyte also expects Q1 FY22 sales of at least $11.0 million, versus the consensus of $8.46 million and $6.5 million in Q1 FY21.
- Core business revenue is expected to be at least $9.0 million, and SPL Program-related revenue is expected to be $2.0 million.
- The Company has engaged executive search firm Korn Ferry to lead a search for a new Chief Financial Officer.
- Price Action: MXCT shares closed 1.92% higher at $5.85 during after-hours trading on Tuesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Date | ticker | name | Actual EPS | EPS Surprise | Actual Rev | Rev Surprise |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in